Development of medical device software for the screening and assessment of depression severity using data collected from a wristband-type wearable device: SWIFT study protocol.

Saved in:
Bibliographic Details
Title: Development of medical device software for the screening and assessment of depression severity using data collected from a wristband-type wearable device: SWIFT study protocol.
Authors: Kishimoto T; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.; i2medical LLC, Kawasaki, Japan., Kinoshita S; Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.; Graduate School of Interdisciplinary Information Studies, The University of Tokyo, Tokyo, Japan., Kikuchi T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Bun S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Sato Hospital, Yamagata, Japan., Kitazawa M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Horigome T; i2medical LLC, Kawasaki, Japan.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Tazawa Y; i2medical LLC, Kawasaki, Japan.; Office for Open Innovation, Keio University, Tokyo, Japan., Takamiya A; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Akasaka Clinic, Tokyo, Japan., Hirano J; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Liang KC; i2medical LLC, Kawasaki, Japan.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan., Koga N; i2medical LLC, Kawasaki, Japan., Ochiai Y; Frontier Business Office, Sumitomo Pharma Co., Ltd., Tokyo, Japan., Ito H; Frontier Business Office, Sumitomo Pharma Co., Ltd., Tokyo, Japan., Miyamae Y; Frontier Business Office, Sumitomo Pharma Co., Ltd., Tokyo, Japan., Tsujimoto Y; Frontier Business Office, Sumitomo Pharma Co., Ltd., Tokyo, Japan., Sakuma K; Asaka Hospital, Koriyama, Japan., Kida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Asaka Hospital, Koriyama, Japan., Miura G; Oizumi Hospital, Tokyo, Japan., Kawade Y; Department of Psychiatry, Tsurugaoka Garden Hospital, Tokyo, Japan.; Nagatsuta Ikoinomori Clinic, Yokohama, Japan., Goto A; Department of Psychiatry, Tsurugaoka Garden Hospital, Tokyo, Japan.; Nagatsuta Ikoinomori Clinic, Yokohama, Japan., Yoshino F; Department of Psychiatry, Tsurugaoka Garden Hospital, Tokyo, Japan.; Nagatsuta Ikoinomori Clinic, Yokohama, Japan.
Source: Frontiers in psychiatry [Front Psychiatry] 2022 Dec 21; Vol. 13, pp. 1025517. Date of Electronic Publication: 2022 Dec 21 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101545006 Publication Model: eCollection Cited Medium: Print ISSN: 1664-0640 (Print) Linking ISSN: 16640640 NLM ISO Abbreviation: Front Psychiatry Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-0640
DOI:10.3389/fpsyt.2022.1025517